相关实验视频
Updated: Jun 28, 2026

13:21
Graphene Coatings for Biomedical Implants
Published on: March 1, 2013
21.3K
化学修饰的GONRs与血红蛋白的生物相容性评估及其毒性评估的细胞病理学研究
Karan Chaudhary1,2, Nitanshu Dhama1, Nilesh Rarokar3
1Department of Chemistry, University of Delhi, Delhi-110007, India. dhanraj_masram27@rediffmail.com.
Dalton transactions (Cambridge, England : 2003)
|December 8, 2023
概括
这项研究在石墨烯氧化物纳米带 (Ni-S-GNR) 上合成了-希夫基复合物. 该材料显示蛋白质兼容性和对肝脏和脏细胞的无毒性,表明其具有生物医学应用的潜力.
科学领域:
- 材料科学 材料科学 材料科学
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
背景情况:
- 过渡金属-Schiff基复合物对生物医学用途有价值,但通常存在于同质系统中.
- 石墨烯氧化物纳米带 (GONRs) 对先进材料开发具有重大兴趣.
- 在GONR上固定复合体可以克服同质催化剂的局限性,并创建基于石墨烯的新型材料.
研究的目的:
- 在氧化石墨烯纳米带 (Ni-S-GNR) 上合成一种新的过渡金属-Schiff基复合物.
- 评估合成的Ni-S-GNR对潜在的生物医学应用的生物相容性和安全性.
- 评估Ni-S-GNR与血红蛋白的相互作用及其细胞毒性.
主要方法:
- 使用3-aminopropyltriethoxysilane,pyridine-2-carbaldehyde和复合的 Ni-S-GNR 的合成.
- 使用各种物理化学技术对Ni-S-GNR进行表征.
- 生物相容性评估包括血红蛋白相互作用研究和大鼠肝脏和脏细胞的组织病理分析.
主要成果:
- 成功合成和描述了Ni-S-GNR.
- 证明Ni-S-GNR与血红蛋白之间的结合相互作用,导致血红蛋白的二级和三级结构发生变化.
- 组织病理学研究证实了Ni-S-GNR对大鼠肝脏和细胞的无毒性.
结论:
- Ni-S-GNR与蛋白质具有相容性,血红蛋白本源结构的最小破坏证明了这一点.
- 合成的Ni-S-GNR材料对重要器官 (肝脏和脏) 是无毒的,这表明它对生物医学应用的安全性.
- 在GONR上固定过渡金属-Schiff基复合体是开发先进,安全的基于石墨烯的生物医学材料的有希望的策略.
相关概念视频
Toxic Reactions: Overview
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Blood Studies I: ABG and VBG
Blood studies are critical in the medical field, enabling healthcare professionals to assess a patient's health status accurately. This page will focus on two significant blood studies: Arterial Blood Gas (ABG) and Venous Blood Gas (VBG).
Arterial Blood Gas (ABG)
Arterial Blood Gas (ABG) studies are crucial for assessing the lungs' ability to supply oxygen and remove carbon dioxide, reflecting the patient's ventilation status. They also help understand the kidneys' capacity to reabsorb or...
Arterial Blood Gas (ABG)
Arterial Blood Gas (ABG) studies are crucial for assessing the lungs' ability to supply oxygen and remove carbon dioxide, reflecting the patient's ventilation status. They also help understand the kidneys' capacity to reabsorb or...
Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...

